Surgery Partners, Inc. Announces Pricing of $279.0 million Public Offering of Common Stock

About this update from Surgery Partners, Inc.

[{"type":"text","content":"BRENTWOOD, Tenn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the pricing of its previously announced underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $46.50 per share. Gross proceeds to Surgery Partners from the offering are expected to be approximately $279.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Surgery Partners. In addition, Surgery Partners has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of its common stock, at the public offering price less underwriting discounts and commissions. All of the shares in the offering are being sold by Surgery Partners. The offering is expected to close on or about November 12, 2021, subject to customary closing conditions. BofA Securities, J.P. Morgan Securities LLC and Jefferies LLC are acting as lead bookrunning managers, and Barclays Capital Inc., SVB Leerink LLC, KKR Capital Markets LLC and Macquarie Capital (USA) Inc. are acting as joint bookrunning managers for the public offering. Surgery Partners intends to use its net proceeds from the public offering for general corporate purposes, which may include, but is not limited to, funding acquisitions, repaying indebtedness, capital expenditures and funding working capital. The shares are being offered pursuant to an effective shelf registration statement that was previously filed with the Securities and Exchange Commission (the “SEC”) on January 25, 2021. A preliminary prospectus relating to the offering was filed with the SEC and is available on the SEC’s website at www.sec.gov. An electronic copy of the final prospectus supplement and accompanying base prospectus relating to the offering, when filed, will be available on the SEC’s website at www.sec.gov and may also be obtained, when available, by contacting BofA Securities NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte, NC 28255-0001, Attn: Prospectus Department, or email at [email protected] or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, Attn: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, or telephone: 1-866-803-9204 or by email at [email protected] or Jefferies LLC, Attention: Equity...

More updates from Surgery Partners, Inc.